H. Pinnock (Edinburgh, United Kingdom), A. Langhammer (Verdal, Norway)
Opioid prescription for patients with COPD or lung cancer in the last 3 months of life
D. Goodridge, J. Lawson, G. Rocker, D. Marciniuk, D. Rennie (Saskatoon, Halifax, Canada)
|   |
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation
R. Dennis, D. Maldonado, M. X. Rojas, P. Aschner, M. Rondon, L. Charry, A. Casas (Bogota, Colombia)
| |
A disease without a clear beginning: longitudinal qualitative study of end-stage COPD
H. Pinnock, M. Kendall, S. Murray, P. Levack, W. MacNee, M. Porter, A. Worth, A. Sheikh (Edinburgh, Dundee, United Kingdom)
| |
A survey of asthma severity, comorbidities and treatments in a paediatric primary care cohort in the UK
M. Thomas, T. M. Thomas, V. Sazonov, S. Taylor, T. Fan (Aberdeen, London, United Kingdom; Whitehouse Station, United States Of America)
| |
Investigation of the prevalence of comorbidities in patients with COPD using the Italian college of general practitioners (SIMG) database
M. Cazzola, G. Bettoncelli, E. Sessa, C. Cricelli, L. M. Fabbri (Rome, Florence, Modena, Italy)
| |
Nutritional status and resting energy expenditure in patients with chronic obstructive pulmonary disease
M. Sugino, K. Yoshimori, H. Katsura, S. Kudoh (Kiyose-shi, Yachiyo, Japan)
| |
Association of anti-depressive medications with clinical outcomes in eclipse
S. Rennard, L. D. Edwards, J. C. Yates, R. Tal-Singer (Omaha, RTP, King of Prussia, United States Of America)
| |
Pilot of a population cohort for the study of the natural history of COPD and OSAS: the pulsaib study
J. B. Soriano, A. Yáñez, F. Renom, M. De la Peña, A. Gómez, R. Duro, M. Román (Bunyola, Palma de Mallorca, Spain)
| |
COPD case management in primary care
J. Brereton, M. Rudolf (Prenton, Southall, United Kingdom)
| |
Utility of N-terminal pro b-type natriuretic peptide (NT-PROBNP) dosage in differential diagnosis of acute dyspnoea
E. Battaglia, C. Bonfardeci, S. Bordoni, S. Amaducci (Milan, Italy)
| |
Long-term results of integrated COPD management in primary care: the Kroonluchter programme
N. Chavannes, J. Adrichem Van, M. Erkelens, H. Veen in ‘t, J. Gussekloo (Leiden, Rotterdam, Netherlands)
| |
Assessing COPD health: what do patients and physicians consider?
G. Harding, L. Roberts, S. Gavriel, L. Murray, P. Berry, I. Wiklund, N. Kline Leidy, P. Jones (Bethesda, United States Of America; London, United Kingdom)
| |
PHQ-9 as a screening tool for depression in patients with COPD in primary care settings
A. Yohannes, M. Deacon (Manchester, United Kingdom)
| |
Temporal effects of analysis delay in arterial blood gas samples in patients with COPD exacerbations and healthy controls
A. I. El Gammal, A. Jahangi, P. P. J. Barry, T. M. O‘Connor (Cork, Ireland)
| |
Electrocardiography and doppler echocardiography as diagnostic methods of cor pulmonale in patients with COPD
N. Karoli, A. Rebrov, V. Sergeeva (Saratov, Russian Federation)
| |
Review of home oxygen prescription for COPD patients at St Helen‘s and Knowsley NHS trust
M. Murthy, S. Church (Prescott, United Kingdom)
| |
Pattern of risk of myocardial infarction (MI) in patients taking asthma medication: a study with the UK general practice research database (GPRD)
B. Zhang, F. De Vries, E. Setakis, T. P. van Staa (London, United Kingdom; Utrecht, Netherlands)
| |
An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
L. Siebeling, G. Ter Riet, W. van der Wal, R. Geskus, M. Zoller, P. Muggensturm, I. Joleska, M. Puhan (Amsterdam, Netherlands; Zurich, Switzerland; Baltimore, United States Of America)
| |
Prevalence and risk factors of depression in patients with COPD
K. H. Lee, J. H. Chung, K. C. Shin, S. K. Yu, H. J. Chin (Daegu, Republic Of Korea)
| |
Miles to go and promises to keep: medical audit of hospitalised asthmatics from Mumbai
A. Kate, Z. A. L. Udwadia (Mumbai, India; Singapore, Singapore)
| |